Entag, Lorna G.

HRN: 29-08-39  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/02/2026
06/09/2026
IV
4.5g
Q6
Dm Foot
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines